International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8418314
Original Article
Cross-sectional study to understand Big Five Personality Traits in patients of Major Depressive Disorder
 ,
Published
Oct. 8, 2023
Abstract
Background: Individuals with MDD differ from non-depressed individuals upon measures of dimensional personality traits. It is found that there has been a complex and variable association between personality and depression. We can decide treatment plan, course of treatment, and prognosis based on this knowledge. Aims: To study the Big Five Personality Traits in Patients of Major Depressive Disorder. Methods: A cross-sectional study was conducted at a tertiary care hospital at the Department of Psychiatry. 100 patients were taken. Personality traits were assessed using the Big Five Inventory focused on domains like Neuroticism, Extraversion, Openness to experience, Agreeableness, and Conscientiousness. The severity of depression was assessed using Hamilton Depression Rating Scale. Other appropriate variables were obtained using semi-structured proforma. Data was analyzed with SPSS Epi Info™ v7.2.5. Linear correlation between two continuous variables was explored using Pearson’s correlation (if the data were normally distributed) and Spearman’s correlation (for non-normally distributed data). Statistical significance was kept atp < 0.05. Results: Correlation of Big Five personality traits was studied with respect to various socio-demographic and clinical variables. Conclusion: Personality trait Neuroticism may be a risk factor in developing major depression. Extraversion, Openness to experience, Agreeableness and Conscientiousness may be associated with some protective effect. An individual-tailored approach to management is advisable for better long-term outcomes based on personality traits.
Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
32 Views
214 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved